nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Imiquimod—skin cancer	0.302	0.452	CbGbCtD
Anagrelide—CYP1A2—Vemurafenib—skin cancer	0.166	0.247	CbGbCtD
Anagrelide—CYP1A2—Dacarbazine—skin cancer	0.127	0.19	CbGbCtD
Anagrelide—CYP1A2—Fluorouracil—skin cancer	0.0744	0.111	CbGbCtD
Anagrelide—Epistaxis—Fluorouracil—skin cancer	0.00053	0.0016	CcSEcCtD
Anagrelide—Visual impairment—Temozolomide—skin cancer	0.000528	0.0016	CcSEcCtD
Anagrelide—Sinusitis—Fluorouracil—skin cancer	0.000528	0.00159	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000527	0.00159	CcSEcCtD
Anagrelide—Ill-defined disorder—Bleomycin—skin cancer	0.000525	0.00159	CcSEcCtD
Anagrelide—Anaemia—Bleomycin—skin cancer	0.000523	0.00158	CcSEcCtD
Anagrelide—Diarrhoea—Vemurafenib—skin cancer	0.000521	0.00158	CcSEcCtD
Anagrelide—Migraine—Docetaxel—skin cancer	0.000518	0.00157	CcSEcCtD
Anagrelide—Urticaria—Imiquimod—skin cancer	0.000516	0.00156	CcSEcCtD
Anagrelide—Abdominal pain—Imiquimod—skin cancer	0.000514	0.00155	CcSEcCtD
Anagrelide—Body temperature increased—Imiquimod—skin cancer	0.000514	0.00155	CcSEcCtD
Anagrelide—Eye disorder—Temozolomide—skin cancer	0.000512	0.00155	CcSEcCtD
Anagrelide—Tinnitus—Temozolomide—skin cancer	0.000511	0.00154	CcSEcCtD
Anagrelide—Malaise—Bleomycin—skin cancer	0.00051	0.00154	CcSEcCtD
Anagrelide—Cardiac disorder—Temozolomide—skin cancer	0.000509	0.00154	CcSEcCtD
Anagrelide—Haemoglobin—Fluorouracil—skin cancer	0.000507	0.00153	CcSEcCtD
Anagrelide—Rhinitis—Fluorouracil—skin cancer	0.000506	0.00153	CcSEcCtD
Anagrelide—Haemorrhage—Fluorouracil—skin cancer	0.000505	0.00153	CcSEcCtD
Anagrelide—Dizziness—Vemurafenib—skin cancer	0.000504	0.00152	CcSEcCtD
Anagrelide—Hypoaesthesia—Fluorouracil—skin cancer	0.000502	0.00152	CcSEcCtD
Anagrelide—Pharyngitis—Fluorouracil—skin cancer	0.000501	0.00151	CcSEcCtD
Anagrelide—Mediastinal disorder—Temozolomide—skin cancer	0.000494	0.00149	CcSEcCtD
Anagrelide—Cough—Bleomycin—skin cancer	0.000493	0.00149	CcSEcCtD
Anagrelide—Chills—Temozolomide—skin cancer	0.000492	0.00149	CcSEcCtD
Anagrelide—Dehydration—Docetaxel—skin cancer	0.00049	0.00148	CcSEcCtD
Anagrelide—Ill-defined disorder—Dactinomycin—skin cancer	0.000489	0.00148	CcSEcCtD
Anagrelide—Anaemia—Dactinomycin—skin cancer	0.000487	0.00147	CcSEcCtD
Anagrelide—Liver function test abnormal—Docetaxel—skin cancer	0.000486	0.00147	CcSEcCtD
Anagrelide—Vomiting—Vemurafenib—skin cancer	0.000484	0.00146	CcSEcCtD
Anagrelide—Alopecia—Temozolomide—skin cancer	0.000484	0.00146	CcSEcCtD
Anagrelide—Dry skin—Docetaxel—skin cancer	0.000483	0.00146	CcSEcCtD
Anagrelide—Chest pain—Bleomycin—skin cancer	0.000481	0.00145	CcSEcCtD
Anagrelide—Myalgia—Bleomycin—skin cancer	0.000481	0.00145	CcSEcCtD
Anagrelide—Orthostatic hypotension—Docetaxel—skin cancer	0.000481	0.00145	CcSEcCtD
Anagrelide—Rash—Vemurafenib—skin cancer	0.00048	0.00145	CcSEcCtD
Anagrelide—Dermatitis—Vemurafenib—skin cancer	0.00048	0.00145	CcSEcCtD
Anagrelide—Headache—Vemurafenib—skin cancer	0.000477	0.00144	CcSEcCtD
Anagrelide—Malnutrition—Temozolomide—skin cancer	0.000477	0.00144	CcSEcCtD
Anagrelide—Discomfort—Bleomycin—skin cancer	0.000476	0.00144	CcSEcCtD
Anagrelide—Malaise—Dactinomycin—skin cancer	0.000476	0.00144	CcSEcCtD
Anagrelide—Asthenia—Imiquimod—skin cancer	0.000466	0.00141	CcSEcCtD
Anagrelide—Confusional state—Bleomycin—skin cancer	0.000465	0.00141	CcSEcCtD
Anagrelide—Oedema—Bleomycin—skin cancer	0.000462	0.00139	CcSEcCtD
Anagrelide—Back pain—Temozolomide—skin cancer	0.000461	0.00139	CcSEcCtD
Anagrelide—Pruritus—Imiquimod—skin cancer	0.00046	0.00139	CcSEcCtD
Anagrelide—Infection—Bleomycin—skin cancer	0.000458	0.00139	CcSEcCtD
Anagrelide—Dysphagia—Docetaxel—skin cancer	0.000455	0.00138	CcSEcCtD
Anagrelide—Nausea—Vemurafenib—skin cancer	0.000452	0.00137	CcSEcCtD
Anagrelide—Thrombocytopenia—Bleomycin—skin cancer	0.000452	0.00137	CcSEcCtD
Anagrelide—Arrhythmia—Fluorouracil—skin cancer	0.000451	0.00136	CcSEcCtD
Anagrelide—Vision blurred—Temozolomide—skin cancer	0.00045	0.00136	CcSEcCtD
Anagrelide—Myalgia—Dactinomycin—skin cancer	0.000449	0.00136	CcSEcCtD
Anagrelide—Alopecia—Fluorouracil—skin cancer	0.000446	0.00135	CcSEcCtD
Anagrelide—Diarrhoea—Imiquimod—skin cancer	0.000444	0.00134	CcSEcCtD
Anagrelide—Discomfort—Dactinomycin—skin cancer	0.000444	0.00134	CcSEcCtD
Anagrelide—Angina pectoris—Docetaxel—skin cancer	0.000443	0.00134	CcSEcCtD
Anagrelide—Ill-defined disorder—Temozolomide—skin cancer	0.000443	0.00134	CcSEcCtD
Anagrelide—Anaemia—Temozolomide—skin cancer	0.000441	0.00133	CcSEcCtD
Anagrelide—Anorexia—Bleomycin—skin cancer	0.00044	0.00133	CcSEcCtD
Anagrelide—Pancytopenia—Docetaxel—skin cancer	0.000432	0.00131	CcSEcCtD
Anagrelide—Hypotension—Bleomycin—skin cancer	0.000431	0.0013	CcSEcCtD
Anagrelide—Oedema—Dactinomycin—skin cancer	0.00043	0.0013	CcSEcCtD
Anagrelide—Malaise—Temozolomide—skin cancer	0.00043	0.0013	CcSEcCtD
Anagrelide—Dizziness—Imiquimod—skin cancer	0.00043	0.0013	CcSEcCtD
Anagrelide—Infection—Dactinomycin—skin cancer	0.000428	0.00129	CcSEcCtD
Anagrelide—Palpitations—Temozolomide—skin cancer	0.000422	0.00127	CcSEcCtD
Anagrelide—Thrombocytopenia—Dactinomycin—skin cancer	0.000421	0.00127	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00042	0.00127	CcSEcCtD
Anagrelide—Cough—Temozolomide—skin cancer	0.000416	0.00126	CcSEcCtD
Anagrelide—Paraesthesia—Bleomycin—skin cancer	0.000414	0.00125	CcSEcCtD
Anagrelide—Weight increased—Docetaxel—skin cancer	0.000414	0.00125	CcSEcCtD
Anagrelide—Vision blurred—Fluorouracil—skin cancer	0.000414	0.00125	CcSEcCtD
Anagrelide—Convulsion—Temozolomide—skin cancer	0.000413	0.00125	CcSEcCtD
Anagrelide—Vomiting—Imiquimod—skin cancer	0.000413	0.00125	CcSEcCtD
Anagrelide—Weight decreased—Docetaxel—skin cancer	0.000412	0.00124	CcSEcCtD
Anagrelide—Hypertension—Temozolomide—skin cancer	0.000412	0.00124	CcSEcCtD
Anagrelide—Dyspnoea—Bleomycin—skin cancer	0.000411	0.00124	CcSEcCtD
Anagrelide—Anorexia—Dactinomycin—skin cancer	0.00041	0.00124	CcSEcCtD
Anagrelide—Rash—Imiquimod—skin cancer	0.00041	0.00124	CcSEcCtD
Anagrelide—Dermatitis—Imiquimod—skin cancer	0.000409	0.00124	CcSEcCtD
Anagrelide—Pneumonia—Docetaxel—skin cancer	0.000408	0.00123	CcSEcCtD
Anagrelide—Headache—Imiquimod—skin cancer	0.000407	0.00123	CcSEcCtD
Anagrelide—Anaemia—Fluorouracil—skin cancer	0.000406	0.00123	CcSEcCtD
Anagrelide—Arthralgia—Temozolomide—skin cancer	0.000406	0.00123	CcSEcCtD
Anagrelide—Myalgia—Temozolomide—skin cancer	0.000406	0.00123	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000403	0.00122	CcSEcCtD
Anagrelide—Discomfort—Temozolomide—skin cancer	0.000401	0.00121	CcSEcCtD
Anagrelide—Decreased appetite—Bleomycin—skin cancer	0.000401	0.00121	CcSEcCtD
Anagrelide—Acute coronary syndrome—Docetaxel—skin cancer	0.0004	0.00121	CcSEcCtD
Anagrelide—Renal failure—Docetaxel—skin cancer	0.000399	0.00121	CcSEcCtD
Anagrelide—Myocardial infarction—Docetaxel—skin cancer	0.000398	0.0012	CcSEcCtD
Anagrelide—Dry mouth—Temozolomide—skin cancer	0.000397	0.0012	CcSEcCtD
Anagrelide—Pain—Bleomycin—skin cancer	0.000395	0.00119	CcSEcCtD
Anagrelide—Conjunctivitis—Docetaxel—skin cancer	0.000395	0.00119	CcSEcCtD
Anagrelide—Confusional state—Temozolomide—skin cancer	0.000393	0.00119	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000392	0.00119	CcSEcCtD
Anagrelide—Oedema—Temozolomide—skin cancer	0.000389	0.00118	CcSEcCtD
Anagrelide—Infection—Temozolomide—skin cancer	0.000387	0.00117	CcSEcCtD
Anagrelide—Nausea—Imiquimod—skin cancer	0.000386	0.00117	CcSEcCtD
Anagrelide—Hepatobiliary disease—Docetaxel—skin cancer	0.000384	0.00116	CcSEcCtD
Anagrelide—Epistaxis—Docetaxel—skin cancer	0.000383	0.00116	CcSEcCtD
Anagrelide—Nervous system disorder—Temozolomide—skin cancer	0.000382	0.00115	CcSEcCtD
Anagrelide—Thrombocytopenia—Temozolomide—skin cancer	0.000381	0.00115	CcSEcCtD
Anagrelide—Convulsion—Fluorouracil—skin cancer	0.000381	0.00115	CcSEcCtD
Anagrelide—Feeling abnormal—Bleomycin—skin cancer	0.00038	0.00115	CcSEcCtD
Anagrelide—Skin disorder—Temozolomide—skin cancer	0.000378	0.00114	CcSEcCtD
Anagrelide—Hyperhidrosis—Temozolomide—skin cancer	0.000376	0.00114	CcSEcCtD
Anagrelide—Chest pain—Fluorouracil—skin cancer	0.000374	0.00113	CcSEcCtD
Anagrelide—Myalgia—Fluorouracil—skin cancer	0.000374	0.00113	CcSEcCtD
Anagrelide—Decreased appetite—Dactinomycin—skin cancer	0.000374	0.00113	CcSEcCtD
Anagrelide—Fatigue—Dactinomycin—skin cancer	0.000371	0.00112	CcSEcCtD
Anagrelide—Anorexia—Temozolomide—skin cancer	0.000371	0.00112	CcSEcCtD
Anagrelide—Discomfort—Fluorouracil—skin cancer	0.00037	0.00112	CcSEcCtD
Anagrelide—Pain—Dactinomycin—skin cancer	0.000368	0.00111	CcSEcCtD
Anagrelide—Urticaria—Bleomycin—skin cancer	0.000367	0.00111	CcSEcCtD
Anagrelide—Haemoglobin—Docetaxel—skin cancer	0.000366	0.00111	CcSEcCtD
Anagrelide—Rhinitis—Docetaxel—skin cancer	0.000365	0.0011	CcSEcCtD
Anagrelide—Body temperature increased—Bleomycin—skin cancer	0.000365	0.0011	CcSEcCtD
Anagrelide—Hepatitis—Docetaxel—skin cancer	0.000364	0.0011	CcSEcCtD
Anagrelide—Haemorrhage—Docetaxel—skin cancer	0.000364	0.0011	CcSEcCtD
Anagrelide—Hypoaesthesia—Docetaxel—skin cancer	0.000363	0.0011	CcSEcCtD
Anagrelide—Confusional state—Fluorouracil—skin cancer	0.000362	0.00109	CcSEcCtD
Anagrelide—Pharyngitis—Docetaxel—skin cancer	0.000362	0.00109	CcSEcCtD
Anagrelide—Urinary tract disorder—Docetaxel—skin cancer	0.00036	0.00109	CcSEcCtD
Anagrelide—Oedema peripheral—Docetaxel—skin cancer	0.000359	0.00108	CcSEcCtD
Anagrelide—Oedema—Fluorouracil—skin cancer	0.000359	0.00108	CcSEcCtD
Anagrelide—Connective tissue disorder—Docetaxel—skin cancer	0.000358	0.00108	CcSEcCtD
Anagrelide—Urethral disorder—Docetaxel—skin cancer	0.000357	0.00108	CcSEcCtD
Anagrelide—Infection—Fluorouracil—skin cancer	0.000356	0.00108	CcSEcCtD
Anagrelide—Feeling abnormal—Dactinomycin—skin cancer	0.000355	0.00107	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000355	0.00107	CcSEcCtD
Anagrelide—Insomnia—Temozolomide—skin cancer	0.000352	0.00106	CcSEcCtD
Anagrelide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000352	0.00106	CcSEcCtD
Anagrelide—Nervous system disorder—Fluorouracil—skin cancer	0.000352	0.00106	CcSEcCtD
Anagrelide—Thrombocytopenia—Fluorouracil—skin cancer	0.000351	0.00106	CcSEcCtD
Anagrelide—Visual impairment—Docetaxel—skin cancer	0.000351	0.00106	CcSEcCtD
Anagrelide—Tachycardia—Fluorouracil—skin cancer	0.00035	0.00106	CcSEcCtD
Anagrelide—Paraesthesia—Temozolomide—skin cancer	0.00035	0.00106	CcSEcCtD
Anagrelide—Dyspnoea—Temozolomide—skin cancer	0.000347	0.00105	CcSEcCtD
Anagrelide—Somnolence—Temozolomide—skin cancer	0.000346	0.00105	CcSEcCtD
Anagrelide—Dyspepsia—Temozolomide—skin cancer	0.000343	0.00104	CcSEcCtD
Anagrelide—Anorexia—Fluorouracil—skin cancer	0.000342	0.00103	CcSEcCtD
Anagrelide—Eye disorder—Docetaxel—skin cancer	0.000341	0.00103	CcSEcCtD
Anagrelide—Abdominal pain—Dactinomycin—skin cancer	0.00034	0.00103	CcSEcCtD
Anagrelide—Body temperature increased—Dactinomycin—skin cancer	0.00034	0.00103	CcSEcCtD
Anagrelide—Decreased appetite—Temozolomide—skin cancer	0.000338	0.00102	CcSEcCtD
Anagrelide—Cardiac disorder—Docetaxel—skin cancer	0.000338	0.00102	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000336	0.00102	CcSEcCtD
Anagrelide—Fatigue—Temozolomide—skin cancer	0.000336	0.00101	CcSEcCtD
Anagrelide—Hypotension—Fluorouracil—skin cancer	0.000335	0.00101	CcSEcCtD
Anagrelide—Pain—Temozolomide—skin cancer	0.000333	0.00101	CcSEcCtD
Anagrelide—Constipation—Temozolomide—skin cancer	0.000333	0.00101	CcSEcCtD
Anagrelide—Asthenia—Bleomycin—skin cancer	0.000331	0.001	CcSEcCtD
Anagrelide—Mediastinal disorder—Docetaxel—skin cancer	0.000328	0.000992	CcSEcCtD
Anagrelide—Chills—Docetaxel—skin cancer	0.000327	0.000988	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000327	0.000988	CcSEcCtD
Anagrelide—Pruritus—Bleomycin—skin cancer	0.000327	0.000987	CcSEcCtD
Anagrelide—Arrhythmia—Docetaxel—skin cancer	0.000326	0.000984	CcSEcCtD
Anagrelide—Insomnia—Fluorouracil—skin cancer	0.000324	0.00098	CcSEcCtD
Anagrelide—Paraesthesia—Fluorouracil—skin cancer	0.000322	0.000973	CcSEcCtD
Anagrelide—Alopecia—Docetaxel—skin cancer	0.000322	0.000973	CcSEcCtD
Anagrelide—Feeling abnormal—Temozolomide—skin cancer	0.000321	0.00097	CcSEcCtD
Anagrelide—Dyspnoea—Fluorouracil—skin cancer	0.00032	0.000966	CcSEcCtD
Anagrelide—Somnolence—Fluorouracil—skin cancer	0.000319	0.000964	CcSEcCtD
Anagrelide—Gastrointestinal pain—Temozolomide—skin cancer	0.000318	0.000962	CcSEcCtD
Anagrelide—Malnutrition—Docetaxel—skin cancer	0.000317	0.000959	CcSEcCtD
Anagrelide—Dyspepsia—Fluorouracil—skin cancer	0.000316	0.000954	CcSEcCtD
Anagrelide—Decreased appetite—Fluorouracil—skin cancer	0.000312	0.000942	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00031	0.000936	CcSEcCtD
Anagrelide—Urticaria—Temozolomide—skin cancer	0.000309	0.000935	CcSEcCtD
Anagrelide—Asthenia—Dactinomycin—skin cancer	0.000309	0.000933	CcSEcCtD
Anagrelide—Body temperature increased—Temozolomide—skin cancer	0.000308	0.00093	CcSEcCtD
Anagrelide—Abdominal pain—Temozolomide—skin cancer	0.000308	0.00093	CcSEcCtD
Anagrelide—Back pain—Docetaxel—skin cancer	0.000307	0.000927	CcSEcCtD
Anagrelide—Pain—Fluorouracil—skin cancer	0.000307	0.000927	CcSEcCtD
Anagrelide—Muscle spasms—Docetaxel—skin cancer	0.000305	0.000922	CcSEcCtD
Anagrelide—Feeling abnormal—Fluorouracil—skin cancer	0.000296	0.000893	CcSEcCtD
Anagrelide—Diarrhoea—Dactinomycin—skin cancer	0.000294	0.00089	CcSEcCtD
Anagrelide—Vomiting—Bleomycin—skin cancer	0.000293	0.000887	CcSEcCtD
Anagrelide—Anaemia—Docetaxel—skin cancer	0.000293	0.000886	CcSEcCtD
Anagrelide—Rash—Bleomycin—skin cancer	0.000291	0.000879	CcSEcCtD
Anagrelide—Dermatitis—Bleomycin—skin cancer	0.000291	0.000879	CcSEcCtD
Anagrelide—Urticaria—Fluorouracil—skin cancer	0.000285	0.000861	CcSEcCtD
Anagrelide—Syncope—Docetaxel—skin cancer	0.000284	0.00086	CcSEcCtD
Anagrelide—Body temperature increased—Fluorouracil—skin cancer	0.000284	0.000857	CcSEcCtD
Anagrelide—Palpitations—Docetaxel—skin cancer	0.00028	0.000847	CcSEcCtD
Anagrelide—Asthenia—Temozolomide—skin cancer	0.000279	0.000844	CcSEcCtD
Anagrelide—Loss of consciousness—Docetaxel—skin cancer	0.000279	0.000843	CcSEcCtD
Anagrelide—Cough—Docetaxel—skin cancer	0.000277	0.000837	CcSEcCtD
Anagrelide—Pruritus—Temozolomide—skin cancer	0.000275	0.000832	CcSEcCtD
Anagrelide—Convulsion—Docetaxel—skin cancer	0.000275	0.000831	CcSEcCtD
Anagrelide—Nausea—Bleomycin—skin cancer	0.000274	0.000828	CcSEcCtD
Anagrelide—Hypertension—Docetaxel—skin cancer	0.000274	0.000828	CcSEcCtD
Anagrelide—Vomiting—Dactinomycin—skin cancer	0.000274	0.000827	CcSEcCtD
Anagrelide—Rash—Dactinomycin—skin cancer	0.000271	0.00082	CcSEcCtD
Anagrelide—Arthralgia—Docetaxel—skin cancer	0.00027	0.000816	CcSEcCtD
Anagrelide—Myalgia—Docetaxel—skin cancer	0.00027	0.000816	CcSEcCtD
Anagrelide—Chest pain—Docetaxel—skin cancer	0.00027	0.000816	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000268	0.000811	CcSEcCtD
Anagrelide—Diarrhoea—Temozolomide—skin cancer	0.000266	0.000805	CcSEcCtD
Anagrelide—Dry mouth—Docetaxel—skin cancer	0.000264	0.000798	CcSEcCtD
Anagrelide—Confusional state—Docetaxel—skin cancer	0.000261	0.000789	CcSEcCtD
Anagrelide—Oedema—Docetaxel—skin cancer	0.000259	0.000782	CcSEcCtD
Anagrelide—Dizziness—Temozolomide—skin cancer	0.000257	0.000778	CcSEcCtD
Anagrelide—Infection—Docetaxel—skin cancer	0.000257	0.000777	CcSEcCtD
Anagrelide—Nausea—Dactinomycin—skin cancer	0.000256	0.000773	CcSEcCtD
Anagrelide—Shock—Docetaxel—skin cancer	0.000255	0.00077	CcSEcCtD
Anagrelide—Nervous system disorder—Docetaxel—skin cancer	0.000254	0.000767	CcSEcCtD
Anagrelide—Pruritus—Fluorouracil—skin cancer	0.000254	0.000767	CcSEcCtD
Anagrelide—Thrombocytopenia—Docetaxel—skin cancer	0.000253	0.000766	CcSEcCtD
Anagrelide—Tachycardia—Docetaxel—skin cancer	0.000253	0.000764	CcSEcCtD
Anagrelide—Skin disorder—Docetaxel—skin cancer	0.000251	0.00076	CcSEcCtD
Anagrelide—Vomiting—Temozolomide—skin cancer	0.000248	0.000748	CcSEcCtD
Anagrelide—Anorexia—Docetaxel—skin cancer	0.000247	0.000746	CcSEcCtD
Anagrelide—Rash—Temozolomide—skin cancer	0.000245	0.000742	CcSEcCtD
Anagrelide—Diarrhoea—Fluorouracil—skin cancer	0.000245	0.000742	CcSEcCtD
Anagrelide—Dermatitis—Temozolomide—skin cancer	0.000245	0.000741	CcSEcCtD
Anagrelide—Headache—Temozolomide—skin cancer	0.000244	0.000737	CcSEcCtD
Anagrelide—Hypotension—Docetaxel—skin cancer	0.000242	0.000731	CcSEcCtD
Anagrelide—Dizziness—Fluorouracil—skin cancer	0.000237	0.000717	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000236	0.000713	CcSEcCtD
Anagrelide—Insomnia—Docetaxel—skin cancer	0.000234	0.000708	CcSEcCtD
Anagrelide—Paraesthesia—Docetaxel—skin cancer	0.000232	0.000703	CcSEcCtD
Anagrelide—Nausea—Temozolomide—skin cancer	0.000231	0.000699	CcSEcCtD
Anagrelide—Dyspnoea—Docetaxel—skin cancer	0.000231	0.000698	CcSEcCtD
Anagrelide—Somnolence—Docetaxel—skin cancer	0.00023	0.000696	CcSEcCtD
Anagrelide—Vomiting—Fluorouracil—skin cancer	0.000228	0.000689	CcSEcCtD
Anagrelide—Dyspepsia—Docetaxel—skin cancer	0.000228	0.000689	CcSEcCtD
Anagrelide—Rash—Fluorouracil—skin cancer	0.000226	0.000683	CcSEcCtD
Anagrelide—Dermatitis—Fluorouracil—skin cancer	0.000226	0.000683	CcSEcCtD
Anagrelide—Decreased appetite—Docetaxel—skin cancer	0.000225	0.00068	CcSEcCtD
Anagrelide—Headache—Fluorouracil—skin cancer	0.000225	0.000679	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000224	0.000675	CcSEcCtD
Anagrelide—Fatigue—Docetaxel—skin cancer	0.000223	0.000675	CcSEcCtD
Anagrelide—Pain—Docetaxel—skin cancer	0.000221	0.000669	CcSEcCtD
Anagrelide—Constipation—Docetaxel—skin cancer	0.000221	0.000669	CcSEcCtD
Anagrelide—Feeling abnormal—Docetaxel—skin cancer	0.000213	0.000645	CcSEcCtD
Anagrelide—Nausea—Fluorouracil—skin cancer	0.000213	0.000644	CcSEcCtD
Anagrelide—Gastrointestinal pain—Docetaxel—skin cancer	0.000212	0.00064	CcSEcCtD
Anagrelide—Abdominal pain—Docetaxel—skin cancer	0.000205	0.000618	CcSEcCtD
Anagrelide—Body temperature increased—Docetaxel—skin cancer	0.000205	0.000618	CcSEcCtD
Anagrelide—Asthenia—Docetaxel—skin cancer	0.000186	0.000561	CcSEcCtD
Anagrelide—Pruritus—Docetaxel—skin cancer	0.000183	0.000554	CcSEcCtD
Anagrelide—Diarrhoea—Docetaxel—skin cancer	0.000177	0.000535	CcSEcCtD
Anagrelide—Dizziness—Docetaxel—skin cancer	0.000171	0.000517	CcSEcCtD
Anagrelide—Vomiting—Docetaxel—skin cancer	0.000165	0.000497	CcSEcCtD
Anagrelide—Rash—Docetaxel—skin cancer	0.000163	0.000493	CcSEcCtD
Anagrelide—Dermatitis—Docetaxel—skin cancer	0.000163	0.000493	CcSEcCtD
Anagrelide—Headache—Docetaxel—skin cancer	0.000162	0.00049	CcSEcCtD
Anagrelide—Nausea—Docetaxel—skin cancer	0.000154	0.000465	CcSEcCtD
